Abstract:There is no pharmacological treatment available to limit progressing neuronal death after cerebral ischemia. Here we show that targeting the interaction of GABAB receptors with CaMKII using a synthetic interfering peptide after an excitotoxic insult in cultured neurons or in brain slices from MCAO‐treated mice restored downregulated GABAB receptor expression and function, normalized aberrant expression of their major effectors, reduced neuronal excitability, activated the Akt survival pathway, and inhibited progressing neuronal death. Cerebral ischemia is the leading cause for long‐term disability and mortality in adults due to massive neuronal death. Currently, there is no pharmacological treatment available to limit progressive neuronal death after stroke. A major mechanism causing ischemia‐induced neuronal death is the excessive release of glutamate and the associated overexcitation of neurons (excitotoxicity). Normally, GABAB receptors control neuronal excitability in the brain via prolonged inhibition. However, excitotoxic conditions rapidly downregulate GABAB receptors via a CaMKII‐mediated mechanism and thereby diminish adequate inhibition that could counteract neuronal overexcitation and neuronal death. To prevent the deleterious downregulation of GABAB receptors, we developed a cell‐penetrating synthetic peptide (R1‐Pep) that inhibits the interaction of GABAB receptors with CaMKII. Administration of this peptide to cultured cortical neurons exposed to excitotoxic conditions restored cell surface expression and function of GABAB receptors. R1‐Pep did not affect CaMKII expression or activity but prevented its T286 autophosphorylation that renders it autonomously and persistently active. Moreover, R1‐Pep counteracted the aberrant downregulation of G protein‐coupled inwardly rectifying K+ channels and the upregulation of N‐type voltage‐gated Ca2+ channels, the main effectors of GABAB receptors. The restoration of GABAB receptors activated the Akt survival pathway and inhibited excitotoxic neuronal death with a wide time window in cultured neurons. Restoration of GABAB receptors and neuroprotective activity of R1‐Pep was verified by using brain slices prepared from mice after middle cerebral artery occlusion (MCAO). Treatment with R1‐Pep restored normal GABAB receptor expression and GABA receptor‐mediated K+ channel currents. This reduced MCAO‐induced neuronal excitability and inhibited neuronal death. These results support the hypothesis that restoration of GABAB receptor expression under excitatory conditions provides neuroprotection and might be the basis for the development of a selective intervention to inhibit progressive neuronal death after ischemic stroke.

Retrograde transport of neurotrophin receptor TrkB-FL induced by excitotoxicity regulates Golgi stability and is a target for stroke neuroprotection

Neuroprotection by cell permeable TAT-mGluR1 peptide in ischemia: synergy between carrier and cargo sequences.

Therapeutic Potential of a TrkB Agonistic Antibody for Ischemic Brain Injury

Interactions established by isoform-specific TrkB-T1 sequences govern inflammatory response and neurotoxicity in stroke

Development of Pleiotropic TrkB and 5-HT4 Receptor Ligands as Neuroprotective Agents

An Agonistic Trkb Mab Causes Sustained Trkb Activation, Delays Rgc Death, And Protects The Retinal Structure In Optic Nerve Axotomy And In Glaucoma

Combinational Pretreatment of Colony-Stimulating Factor 1 Receptor Inhibitor and Triptolide Upregulates BDNF-Akt and Autophagic Pathways to Improve Cerebral Ischemia

Targeting TrkB-PSD-95 coupling to mitigate neurological disorders

Tissue kallikrein alleviates glutamate-induced neurotoxicity by activating ERK1.

The Rab11-regulated endocytic pathway and BDNF/TrkB signaling: Roles in plasticity changes and neurodegenerative diseases

Brain-Derived Neurotrophic Factor-TrkB Pathway on Synaptic Plasticity in Ischemic Stroke Rats.

Targeting the interaction of GABAB receptors with CaMKII with an interfering peptide restores receptor expression after cerebral ischemia and inhibits progressive neuronal death in mouse brain cells and slices

TrkB/BDNF signaling pathway and its small molecular agonists in CNS injury

Neuroprotection against ischaemic brain injury by a GluR6-9c peptide containing the TAT protein transduction sequence.

Chronic and Acute Models of Retinal Neurodegeneration TrkA Activity Are Neuroprotective Whereas P75ntr Activity is Neurotoxic Through a Paracrine Mechanism

Neuroglobin, a Novel Target for Endogenous Neuroprotection Against Stroke and Neurodegenerative Disorders.

The Janus face of endogenous neuronal tPA: promoting self-protection and worsening the death of neighboring neurons

TAT-Ngn2 Enhances Cognitive Function Recovery and Regulates Caspase-Dependent and Mitochondrial Apoptotic Pathways after Experimental Stroke

Indirect influence on the BDNF/TrkB receptor signaling pathway via GPCRs, an emerging strategy in the treatment of neurodegenerative disorders

A Small TAT-TrkB Peptide Prevents BDNF Receptor Cleavage and Restores Synaptic Physiology in Alzheimer's Disease

Tetramethylpyrazine nitrone activates the BDNF/Akt/CREB pathway to promote post-ischaemic neuroregeneration and recovery of neurological functions in rats.